By Tuck Wong
UK Research and Innovation (UKRI) has allocated investments to four vaccine manufacturing research hubs, including the UK-SEA Vax Hub. This initiative aims to tackle the challenges associated with vaccine manufacturing and distribution in developing nations.
It was an incredibly successful gathering where collaboration and innovation took centre stage. Grateful to all who participated and contributed to this milestone moment.
The UK-South East Asia Vaccine Manufacturing Research Hub was among the highlighted projects during the recent visit of the Foreign Secretary to Thailand.
Rachel Park serves as the Director for International Business at EuBiologics (South Korea) and holds a position on the board of the Developing Countries Vaccine Manufacturing Network (DCVMN).
